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Abstract
Background: Hepatitis B virus (HBV) genotype appears to show varying geographic distribution.
Molecular epidemiological study of HBV in particular areas in Indonesia is still limited. This study
was aimed to identify the prevalence of HBV genotype/subgenotype and mutations in basal core
promoter (BCP) region in voluntary blood donors in Makassar, one of the biggest cities in east part
of Indonesia.
A total of 214 hepatitis B surface antigen (HBsAg)-positive samples were enrolled in this study. HBV
genotype/subgenotype was identified by genotype-specific PCR method or direct sequencing of
pre-S region. Mutations in BCP were identified by direct sequencing of the corresponding region.
Results: HBV/B and HBV/C were detected in 61.21% and 25.23% of the samples, while mix of
HBV/B and HBV/C was found in 12.62% of the samples. Based on pre-S region, among HBV/B and
HBV/C, HBV/B3 (95.00%) and HBV/C1 (58.82%) were predominant. Interestingly, HBV/D was
identified in two samples (22.165.07 and 22.252.07). Complete genome sequences of two HBV/D
strains (22.165.07 and 22.252.07) demonstrated that both strains belong to HBV/D6, and the
divergence between the two strains were 1.45%, while divergences of both 22.165.07 and
22.252.07 strains with reference strain (AM422939/France) were 2.67%. A1762T/G1764A
mutation was observed in 1.96% and 5.36%, whereas T1753V mutation was found in 2.94% and
1.79% of HBV/B and HBV/C, respectively.
Conclusion: HBV/B and HBV/C are dominant in Makassar, similar to most areas in Indonesia.
Mutations in BCP which might be associated with severity of liver disease are less common.
Background
Hepatitis B virus (HBV) infection is a major health prob-
lem leading to significant morbidity and mortality world-
wide. Approximately, two billion people in the world
have been infected by HBV [1]. The majority of acute HBV
infections are self-limiting, whereas chronic HBV infec-
tion can cause chronic hepatitis, liver cirrhosis, or hepato-
cellular carcinoma. It is well known that Indonesia has a
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moderate to high endemicity of hepatitis B virus (HBV)
infection [2], due to the lack of proper health facilities or
poor economical status and less public awareness.
HBV, a member of the Hepadnaviridae, is a relaxed circular
double-stranded DNA virus, and is currently classified
into eight genotypes (A-H) based on a comparison of the
entire HBV genomic sequence [3]. HBV genotypes appear
to show varying geographic distribution. For instance,
HBV/A is prevalent in Europe, Africa, and India [4,5].
HBV/B and HBV/C are predominant in most part of Asia,
including China and Japan [4,6]. The HBV/D is common
in the Mediterranean area, the Middle East and India,
whereas the HBV/E is localized in sub-Saharan Africa [4-
10]. The HBV/F and HBV/H is only identified in Central
and South America [4,11-13]. The HBV/G has been found
in France, Germany and United States [14-16].
Molecular epidemiological studies of HBV, either a
nationwide study or study on particular areas in Indone-
sia, have shown that HBV/B and HBV/C are the most prev-
alent genotypes in Indonesia [2,17-20], although HBV/A
and HBV/D have also been found in Eastern Indonesia,
such as Moluccas and Papua [19,20]. Particularly in South
Moluccas, the prevalence of HBV/D is high, ranging from
50–88% [20]. In the same study, analysis of 12 samples
from Makassar demonstrated that only genotype B and C
were found in the samples [20]. To date, there is no com-
prehensive study about HBV genotype prevalence as well
as the genetic analysis of HBV circulated in Makassar. In
this study, we have analyzed HBV genotype/subgenotype
and mutations in BCP region from voluntary blood
donors in Makassar, which is located in Wallace territory
and the biggest city in Eastern Indonesia.
Methods
Samples
Serum samples from 214 blood donors (age 18–64 years,
mean 30.9 ± 10.3 years, male/female 153/61) which were
positive for HBsAg were collected in the Blood Transfu-
sion Unit, Red Cross Makassar, South Sulawesi, Indone-
sia, between February and August 2007. HBsAg was
determined by commercially available kit (AxSYM®
HBsAg, Abbott Laboratories, Chicago, IL, USA). Blood
samples were separated into sera and stored at -70°C until
use. The study was approved by the Institutional Ethic
Committee and informed consent was obtained from
each donor.
Viral DNA extraction and genotyping
HBV DNA was extracted from 200 μl serum using
QIAamp®  DNA blood mini kit (Qiagen, Hilden, Ger-
many) according to the manufacturer's instruction, and
50 μl eluted DNA was stored at -70°C until use. HBV gen-
otyping was performed by PCR using genotype specific
primers as described by Naito et al. [21]. To avoid false-
positive results, instruction to prevent cross-contamina-
tions were strictly followed, and results considered valid
only when they were obtained in duplicate. Pre-S region
was amplified by nested PCR using PCR Core System
(Promega, Madison, WI, USA) and two sets of primers as
previously described with minor modifications [22]. The
first round PCR was performed for 35 cycles of 95°C for 1
min, 46.7°C for 30 s and 72°C for 1 min. The second
round PCR was carried out similar to the first round PCR,
except with an annealing temperature of 44.6°C. Primers
PS1/PS2 and PS3/PS4 were used for the first and second
rounds PCR, respectively. The PCR products were purified
with Wizard® SV Gel and PCR Clean-Up System (Promega,
Madison, WI, USA), directly sequenced employing an ABI
3130xl Genetic Analyzer (Applied Biosystems, Inc., Foster
City, CA, USA) with the Big Dye Terminator V3.1 Cycle
Sequencing kit (Applied Biosystems, Inc.) using primers
P3 and P4. Multiple alignments of pre-S sequences were
done using the CLUSTAL W method [23]. Phylogenetic
trees were constructed using Neighbor-Joining method
[24] with Kimura's two-parameter [25] and 1,000 repli-
cates of bootstrap resampling as implemented in MEGA
4.1 [26]. Subgenotypes were assigned as described previ-
ously [19,27,28].
Full sequencing of HBV genotype D
The complete genome of HBV was amplified as 7 overlap-
ping fragments (fragment 1–7) using nested-PCR with Go
Taq PCR Core System (Promega). The list of primers and
PCR products are shown in Table 1. First and second
round PCR were performed for 35 cycles with same con-
dition except for annealing temperature. The condition
was as follow: denaturation at 95°C (5 min), annealing at
48.1–57.4°C (30 s) for the first round and 46.1–57.4°C
(30 s) for the second round, and elongation at 72°C (1
min). PCR product was purified from agarose gel using
Wizard® SV Gel and PCR Clean-Up System (Promega),
according to manufacturer's protocol, and directly
sequenced. Percentage divergence of nucleotide sequences
among HBV genotype D strain was calculated using
MEGA 4.1 [26]. Phylogenetic trees were constructed simi-
larly as in the pre-S sequences.
BCP Mutations analysis
BCP region was amplified by hemi-nested PCR using
HBPr86/HBPr7 and HBPr87/HBPr 7 for two rounds PCR
as previously described, with a slightly modified touch-
down PCR [15]. The following cycling parameters were
used for PCR: denaturation at 95°C (30 s), annealing at
60.5–53.5°C (30 s) and elongation at 72°C (30 s). For the
first 15 cycles, the annealing temperature was 60.5°C; this
temperature was then reduced by 0.5°C per cycle, and
continued with constant annealing temperature for
another 30 cycles. The first and second rounds PCR wereVirology Journal 2009, 6:128 http://www.virologyj.com/content/6/1/128
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performed similarly except for annealing temperature
(58.5–51.5°C). The PCR products were purified with Wiz-
ard® SV Gel and PCR Clean-Up System (Promega) and
directly sequenced using primer HBPr7. Multiple align-
ments of BCP sequences were done using the same
method as in the pre-S sequences.
Results
HBV genotype prevalence
Of the 214 subjects enrolled in this study, 156 samples
(72.90%) could be genotyped by genotype-specific PCR,
whereas 58 samples (27.10%) could not. Based on this
method, it was found that 91 samples (58.33%) were
HBV/B, 37 samples (23.72%) were HBV/C, 27 samples
(17.31%) were mix of HBV/B and HBV/C, and one sam-
ple (0.64%) was HBV/D (Table 2). For 58 samples that
could not be identified by genotype-specific PCR, the pre-
S region was amplified and directly sequenced. Of 58 sam-
ples, 40 samples (68.97%) were HBV/B, and 38 of those
HBV/B (95.00% of HBV/B or 65.52% of all samples) were
HBV/B3 and the other two isolates were HBV/B5 (Fig. 1,
Table 2). Seventeen (29.31%) of 58 samples were HBV/C,
which was divided into HBV/C1 (58.82% of HBV/C or
17.24% of all samples) and HBV/C2 (41.18% of HBV/C
or 12.07% of all samples). In addition, HBV/D was only
found in one sample. From HBV genotyping based on
both genotype-specific PCR and pre-S sequence on 214
blood donors, it was shown that HBV/B was predominant
(131 samples, 61.21%), followed by HBV/C (54 samples,
25.23%), mix of HBV/B and HBV/C (27 samples,
12.62%), and HBV/D (2 samples, 0.93%) (Table 2).
Full sequence of HBV genotype D
Since HBV/D is rare in this area, we interested to analyze
the complete genome of the two HBV/D strains
(22.165.07 and 22.252.07) found in the samples. Phylo-
genetic analysis of complete genome, partial S, and pre-C/
C regions confirmed that the two viruses were HBV/D6
(Fig. 2). Percentage divergences of complete genome, pre-
S/S, X, pre-C/C, and Pol genes among the two strains were
1.45%, 1.45%, 1.40%, 0.43%, and 2.19%, respectively.
Based on the complete genome, divergences of 22.165.07
strain with reference strains, AM422939 (France),
AB493846 (Papua), and AB493845 (Papua) were 2.67%,
1.44% and 2.03%, respectively (Table 3). Similarly,
another strain (22.252.07) showed 2.67%, 1.18%, and
1.90% divergences with those three reference strains.
Based on each gene, the two present strains demonstrated
high identity with AB493846 (Papua) in X genes, with
identity of 99.57–100.00%, but less homology with
Table 1: Primers used for fragments amplification and sequencing of complete genome of HBV genotype D
Fragment no. (bp) Primers* Polarity Sequence (5'→'3) Domain Position
1 (379) HBPr1 Forward GGGTCACCATATTCTTGGG HBPol 2850–2860
HBPr2 Forward GAACAAGAGCTACAGCATGGG HBPol/PreS1 2867–2888
HBPr3 Reverse CCACTGCATGGCCTGAGGATG PreS1/PreS2/HBPol 3226–3246
2 (891) HBPr14 Forward TGGGGTGGAGCCCTCAG PreS1/HBPol 3104–3120
HBPr94 Reverse GGTAWAAAGGGACTCAMGATG HBPol/HBsAg 775–795
HBPr135 Reverse CARAGACAAAAGAAAATTGG HBPol/HBsAg 803–822
3 (541) HBPr440 Forward TATGGATGATGTGGTATTGGG HBPol/HBsAg 738–758
HBPr113 Reverse CCGGCAGATGAGAAGGCACAGACGG HBX/HBPol 1549–1574
HBPr374 Reverse GTTCCGCAGTATGGATCGGCAGAGG HBPol 1255–1279
4 (319) HBPr110 Forward CCTCTGCCGATCCATACTGCGGAAC HBPol 1255–1279
HBPr113 Reverse CCGGCAGATGAGAAGGCACAGACGG HBX/HBPol 1549–1574
5 (560) HB1 Forward GCCAAGTGTTTGCTGACGC HBPol 1174–1192
HB2 Forward CCATACTGCGGAACTCCTAG HBPol 1265–1284
HB3 Reverse AAAGTTGCATGGTGCTGGTG HBX 1803–1822
6 (726) HBPr86 Forward ACATAAGAGGACTCTTGGAC HBX 1652–1671
HBPr87 Forward TACTTCAAAGACTGTGTGTTTA HBX 1704–1723
HBPr111 Reverse CTGCGAGGCGAGGGAGTTCTTCTTC Core/HBPol 2406–2430
7 (585) HBPr33 Reverse CTGAGGGCTCCACCCCA PreS1/HBPol 3104–3120
HBPr446 Forward GGAGTGTGGATTCGCACTCC Core 2303–2323
HBPr448 Reverse CCCATGCTGTAGCTCTTGTTC HBPol/PreS1 2868–2888
* All primers, except HB1–HB3, were same as previous report [15].Virology Journal 2009, 6:128 http://www.virologyj.com/content/6/1/128
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Phylogenetic analysis of pre-S region of HBV Figure 1
Phylogenetic analysis of pre-S region of HBV. Phylogenetic tree was constructed from the pre-S sequences of 58 sam-
ples (accession number EU926161–EU926217) together with sequences retrieved from GenBank.
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AM422939 (France) in pre-C/C region, which showed
only 95.62% identity (Table 3).
Genetic variation in BCP region
In order to find out specific nucleotide substitution
among HBV in the subjects, BCP region was analyzed. Of
214 samples, 169 were positive for PCR and sequencing,
however 9 samples could not be analyzed due to incom-
plete data. BCP sequence of HBV/B (102 samples), HBV/
C (56 samples), and HBV/D (2 samples) were respectively
aligned. It was observed that overall nucleotide substitu-
tion was rarely occurred in all genotypes. Double muta-
tion (A1762T/G1764A), one of significant mutations
associated with advanced liver disease including HCC,
was only found in 1.96% (2/102) of HBV/B (Fig. 3). Like-
wise, the double mutation was only observed in 5.36%
(3/56) of HBV/C (Fig. 3). Analysis of nucleotide at posi-
tion 1753 showed that a T-to-V (A/G/C) mutation, which
also suggested having association with liver disease pro-
gression, was found as much as 2.94% (3/102) and 1.79%
(1/56) in HBV/B and HBV/C, respectively. None of these
mutations was identified in HBV/D (Fig. 3). However, a
G-to-A substitution at nucleotide 1896, which prevents
the production of HBeAg by introducing a premature stop
codon into the open reading frame of the pre-C region,
was found in both strains of HBV/D (data not shown).
Discussion
The present study demonstrates that HBV/B (61.21%) and
HBV/C (25.23%) were the most prevalent among HBsAg-
positive blood donors in Makassar, South Sulawesi,
although HBV/D was also rarely found in the samples.
Analysis of pre-S sequence of 58 samples revealed that in
HBV/B the percentage of HBV/B3 was much higher than
HBV/B5. In HBV/C, on the other hand, HBV/C1 and HBV/
C2 were detected with similar frequency.
HBV/B3 is widely distributed in Indonesia, but has not
been reported in other countries, suggesting that HBV/B3
is indigenous to Indonesia [20]. The HBV types we found
in Makassar are similar to those reported in previous stud-
ies from several areas in Indonesia [2,17-19], but the fre-
quencies are different to Papua and Moluccas in where
HBV/C is more dominant [19,20]. In addition, no HBV/A
was found in Makassar, although it was found in Balikpa-
pan and Kupang [20].
Several studies have reported the prevalence of HBV gen-
otype from blood donors in the southern Asian region. A
study from Thailand demonstrated that HBV/A, HBV/B
and HBV/C were detected among blood donors, where
HBV/C (89.3%) was the most prevalent compared to
HBV/B (7.4%) and HBV/A (0.5%) [29]. Although this
study did not identify the subgenotype, complete genome
analysis of HBV/C from Thailand and some other coun-
tries which are geographically close to Indonesia such as
Vietnam and Myanmar showed that most of HBV/C was
classified into HBV/C1 [28], whereas in Makassar HBV/C1
and HBV/C2 were dominant. On the other hand, analysis
of asymptomatic HBV carriers from the Philippines
showed that the prevalence of HBV/B, HBV/C, HBV/D,
mix of HBV/B and HBV/D, and HBV/A were 53.4, 21.4,
14.3, 7.1, and 3.6%, respectively [30]. In general, the per-
centage of HBV/B in the Philippines was similar to that in
Makassar, although it is not possible to compare the sub-
genotypes with the available data. However, all HBV/C
strains in the Philippines samples were classified into
HBV/C5, which is different with subgenotypes circulated
in Makassar (HBV/C1 and HBV/C2). A study from Malay-
sia using small number of healthy blood donors and
chronic hepatitis B carriers demonstrated that HBV/C,
HBV/B, and HBV/D were identified in the samples [31],
which is quite similar to our findings in Makassar.
Studies from India demonstrated that the distribution of
HBV genotype in blood donors was slightly different
between Eastern and Southern India. In Eastern India,
beside the major HBV genotypes transmitted in India such
Table 2: HBV genotype analysis of samples based on genotype specific PCR and pre-S sequence.
No. (%) based on
Genotype/Subgenotype Genotype-specific PCR Pre-S sequence All
B 91 (58.33) 40 (68.97) 131 (61.21)
B3 38 (65.52)
B5 2 (3.45)
C 37 (23.72) 17 (29.31) 54 (25.23)
C1 10 (17.24)
C2 7 (12.07)
B + C 27 (17.31) 0 (0.00) 27 (12.62)
D 1 (0.64) 1 (1.72) 2 (0.93)
Total 156 (100.00) 58 (100.00) 214 (100.00)Virology Journal 2009, 6:128 http://www.virologyj.com/content/6/1/128
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Phylogenetic analysis of complete genome (A), partial S (B) and pre-C/C (C) of HBV/D isolate 22.165.07 and 22.252.07 (acces- sion number EU921418 and EU921419) Figure 2
Phylogenetic analysis of complete genome (A), partial S (B) and pre-C/C (C) of HBV/D isolate 22.165.07 and 
22.252.07 (accession number EU921418 and EU921419). Phylogenetic trees were constructed from sequences of each 
region of HBV genome from the samples and sequences retrieved from GenBank. The sequences used for partial S and pre-C/
C were nucleotide no. 500–703 and 1814–2452, respectively, as described in previous report [19].
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as HBV/D (56.0%) and HBV/A (20.6%), quite high per-
centage of HBV/C (23.4%) was also found in the blood
donors [32]. Phylogenetic analysis revealed that those
HBV/C strains that clustered with HBV/C found in South-
East Asia including Indonesia were classified as HBV/C1
[32]. On the other hand, in Southern India, only HBV/D
(76.11%) and HBV/A (11.94%) were detected [33], simi-
lar to the HBV genotype distribution pattern in Northern
and Western India [5].
In China, HBV/C was detected in high percentage (68.0%)
from blood donors along with HBV/B (25.8%), HBV/A
(2.1%) and mix HBV/B and HBV/C (4.1%), although the
subgenotype was not identified in this study [34]. Thus, in
general, the distribution of HBV genotype from blood
donors in Makassar is different to that in India and China.
Prior to our study, in Indonesia HBV/D has only previ-
ously been found in Papua and Moluccas [19,20]. There-
fore, we were interested to analyze the complete genome
of the two HBV/D strains (22.165.07 and 22.252.07)
found in our samples from Makassar. Phylogenetic analy-
sis of complete genome, partial S, and pre-C/C regions
confirmed that the two HBV/D strains were subgenotype
D6 (Fig. 2). The present HBV/D strains were then com-
pared with two references recently published from Papua
Table 3: Percentage divergences of nucleotide sequences between present and reference strains
22.165.07 22.252.07
Region 22.252.07 AM422939 
(France)
AB493846 
(Papua)
AB493845 
(Papua)
22.165.07 AM422939 
(France)
AB493846 
(Papua)
AB493845 
(Papua)
Complete 
Genome
1.45 2.67 1.44 2.03 1.45 2.67 1.18 1.90
Pre-S/S 1.45 1.79 2.55 2.55 1.45 1.88 2.39 2.71
Polymerase 1.40 2.16 1.25 1.65 1.40 2.20 1.02 1.57
X gene 0.43 1.72 0.43 2.45 0.43 1.29 0.00 2.00
Pre-C/C 2.19 4.38 1.23 2.13 2.19 4.38 0.97 1.95
Alignment of BCP sequences Figure 3
Alignment of BCP sequences. The BCP sequences of HBV/B of 102 samples (accession number EU938143–EU938244), 
HBV/C of 56 samples (accession number EU938245–EU938300), and HBV/D of 2 samples (accession number EU921418 and 
EU921419) were aligned.
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                            ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|.. 
AB033555-Indonesia-(B)      ATGAGTGGGAGGAGTTGGGGGAGGAGATCAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGTTCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCATGTTCATGTCCTATTGTTCAAGCCTCCAAGCTGTGC  
DQ993709-Taiwan-(B)         C...........................T............................................G..............................................TC............C......................  
22.013.07-(B)               C.........................G.T.........................................................................................................C.---------------------  
22.020.07-(B) (3 samples)   C...........................T.........................................................................................................C...............-------  
22.023.07-(B) (71 samples)  ......................................................................................................................................C......................  
22.028.07-(B) (12 samples)  ............................T.........................................................................................................C..........------------  
22.040.07-(B)               ..........A.GAG.......................................................................................................................C......................  
22.066.07-(B)               ...................................................................................................................................T..C......................  
22.075.07-(B)               G..........................CT.......T.A.................................................................................C.............C......................  
22.100.07-(B)               C..........................CT.......T.A...............................................................................................C......................  
22.107.07-(B)               C........................................................................................A............................................C----------------------  
22.117.07-(B)               .A....................................................................................................................................C......................  
22.168.07-(B)               .A..C.......................T.........................................................................................................C......................   
22.204.07-(B)               ..........................G.T.........................................................................................................C......................   
22.205.07-(B)               ......................................................................................................................................C.....................-   
22.209.07-(B)               .................................................................................................................................G....C.....................-   
22.243.07-(B)               ...........................C..........................................................................................................C......................   
22.012.07-(B)               C...........................G...........................................................C..................................----------------------------------   
22.053.07-(B)               ............................T................................................................................................--------------------------------   
22.230.07-(B)               --------------------..................................................................................................................C......................  
22.231.07-(B)               --....................................................................................................................................C......................  
 
M38454-(C)                  .G..C.......................T....................G....................................................................................C......................  
AB298721-Japan-(C)          .A..C.......................T.......T.A...............................................................................................C......................  
22.002.07-(C) (17 samples)  .G..C.......................T....................G....................................................................................C..........------------  
22.003.07-(C) (2 samples)   .G..C.......................T....................G...................................................................----------------------------------------  
22.011.07-(C)               .A..C.......................T.......T.A..............................................................................................CC.................-----  
22.015.07-(C)               .G..C.......................T....................G..................................................................................-------------------------  
22.016.07-(C)               .G..C.......................T....................G...................................................................................CC.A--------------------  
22.017.07-(C)               .G..C.......................T....................G.................................................................................--------------------------  
22.018.07-(C)               .A..C.......................T....................G........................................................................-----------------------------------  
22.021.07-(C)               .G..C.......................T....................G...................................................................T................C......................  
22.022.07-(C)               .G..C.......................T....................G................................................................................---------------------------  
22.024.07-(C)               .G..C.......................T....................G..............................................................................-----------------------------  
22.026.07-(C)               .G..C.......................T....................G...........................................................................A........C................------  
22.032.07-(C)               .G..C.......................T....................G.................................................................................--------------------------  
22.033.07-(C)               .G..C.......................T....................G.................................................................................--------------------------  
22.077.07-(C) (22 samples)  .A..C.......................T....................G....................................................................................C......................  
22.102.07-(C)               .G..C......................CT.......T.A..........G...................................................................................CC......................  
22.135.07-(C)               .G..C.......................T....................G.........................................................A..G.......................C......................  
22.242.07-(C)               ............................T.........................................................................................................C......................  
22.250.07-(C)               .A..........................T.........................................................................................................C......................  
 
DQ315776-India-(D)          .A..C.......................T...............................................CG..........................................T.............C...................... 
AM422939-French-(D)         .A..C.......................T...............................................CG..........................................T.............C......................  
22.165.07-(D)               .A..C.......................T..A............................................CG..........................................T.............C......................  
22.252.07-(D)               .A..C.......................T..A............................................CG..........................................T.............C......................  Virology Journal 2009, 6:128 http://www.virologyj.com/content/6/1/128
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(AB493846 and AB493846) and one reference which
found in France (AM422939). Based on the complete
genome, divergences between the present strains and
Papua strains (HBV/D6) were lower than the divergence
between the two strains and France strain (HBV/D3) (Fig.
2). Thus, it is confirmed that the HBV/D found in Makas-
sar was the same with the HBV/D strains present in Papua
(HBV/D6) [19]. Because a previous study found HBV/D
strains in Moluccas were HBV/D1 and HBV/D3 [20], it is
possible that the HBV/D found in Makassar has been
imported from Papua, not Moluccas, even though Moluc-
cas is very close to Makassar.
Many studies have demonstrated that HBV mutations,
including mutations in BCP region, are linked with the
severity and outcome of HBV infection [35-37]. Our
recent data also revealed that mutations in BCP were asso-
ciated with clinical outcome of liver disease [38]. We
therefore looked for mutations in the BCP region. Double
mutation (A1762T/G1764A) was only found in 1.96% of
HBV/B (Fig. 3). Likewise, the double mutation was only
observed in 5.36% of HBV/C (Fig. 3). Analysis of the
nucleotide at position 1753 showed that a T-to-V (A/G/C)
mutation, which has also been associated with HCC
development [39], was found to be less frequent in both
HBV/B and HBV/C (2.94% and 1.79, respectively). None
of these mutations was identified in HBV/D (Fig. 3).
Hence, our results demonstrated that the frequency of
mutations in BCP in blood donors in Makassar was low.
In our previous study, we included 15 HBV-associated
liver disease samples from Makassar [38], and found that
the prevalence of T1753V and A1762T/G1764A muta-
tions were 40.0% and 60.0%, respectively, suggesting that
those mutations were associated with severity of liver dis-
ease. Since both T1753V and A1762T/G1764A mutations
were less common in blood donors, the chance of devel-
oping severe liver disease might be relatively low in the
blood donors in Makassar.
In comparison, a study from Indian blood donors showed
that the occurrence of double mutation in BCP was
extremely high in HBV/C (72.4%) and relatively high in
HBV/A (24.1%) and HBV/D (21.5%) [32]. Another study
also reported that K130M and V131I substitutions, which
are corresponding to double mutation in BCP, from
Indian inactive carrier were generally high (36.0%) [40].
However, they found that the occurrence of other muta-
tions suggested to have associated with HCC was low [40].
If BCP mutation is strongly associated with clinical out-
come of liver disease including HCC, the incidence of
HCC must be high in India. In fact, the HCC incidence
was very low in India [41], thus the association of BCP
mutations as well as other mutations with severity of liver
disease might be not depend only on virus mutations, but
also host factors, and therefore needs further investiga-
tion.
Conclusion
HBV/B and HBV/C are dominant in Makassar, similar
with the HBV genotype distribution in most areas in Indo-
nesia. Mutations in BCP which might be associated with
severity of liver disease are less common.
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